Tech Company Financing Transactions
Find Therapeutics Funding Round
adMare BioInnovations, CTI Life Sciences Fund and Investissement Quebec participated in a $7.2 million venture round for Find Therapeutics. The round was announced on 1/9/2026.
Transaction Overview
Company Name
Announced On
1/9/2026
Transaction Type
Venture Equity
Amount
$7,200,000
Round
Undisclosed
Proceeds Purpose
With this additional funding, we are well-equipped to drive our pipeline forward, including conducting a de-risking Phase 1b PET trial and achieving Phase 2-readiness.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7171 Frederick-Banting
Saint-Laurent, Québec, H4S 1Z9
Canada
Saint-Laurent, Québec, H4S 1Z9
Canada
Phone
Website
Email Address
Overview
Find Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of next-generation therapies to treat demyelinating diseases, such as Chronic Optic Neuropathy and Multiple Sclerosis. The company is based on technology and know-how from scientific founder Dr. Dominique Bagnard, Professor at the University of Strasbourg through an exclusive license with SATT Conectus.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frédéric Auger
Browse more venture capital transactions:
Prev: 1/9/2026: Apella venture capital transaction
Next: 1/9/2026: Payhawk venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs